Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Fine Organic Industries Limited (FINEORG.NS)
Mumbai, IN
Fine Organic Industries Limited is a company specializing in the worldwide production, processing, and trade of oleochemical-based additives. Operating in both India and international markets, their product range encompasses food additives, such as emulsifiers, antifungal agents, and other custom blends. They also supply the plastics industry with a variety of additives, including dispersing agents, processing aids, anti-static compounds, flow improvers, lubricants, slip agents, and antifogging solutions for use in polymers, masterbatches, foamed products, PVC items, and engineering plastics. Furthermore, the company develops specialized additives for cosmetic, pharmaceutical, coating, and various other industrial applications. Founded in 1970, Fine Organic Industries Limited is headquartered in Mumbai, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.38% | -1.65% | -0.33% | -2.07% | +4.39% | +12.06% | -3.48% | +2.57% | +58.91% | +460.61% | +460.61% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 6 | 0 |
| Hold | 0 | 0 |
| Sell | 2 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+4.3% Q1'26: +2.4% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+1.6% Q1'26: +21.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+13.6% ★ Q1'26: +19.8% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+18.0% ★ Q1'26: +17.9% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+25.5% ★ Q1'26: +28.7% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.14× ★ Q1'26: 0.13× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 8 Rev. Ana. 6 EPS Ana. |
Mar 2027 9 Rev. Ana. 7 EPS Ana. |
Mar 2028 9 Rev. Ana. 9 EPS Ana. |
Mar 2029 2 Rev. Ana. 2 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
10.60B
est: 10.41B (+1.9%)
|
10.38B
est: 11.19B (-7.2%)
|
11.33B
est: 11.00B (+3.0%)
|
18.76B
est: 18.71B (+0.3%)
|
30.23B
est: 30.81B (-1.9%)
|
21.23B
est: 21.25B (-0.1%)
|
22.69B
est: 22.13B (+2.6%)
|
23.44B
22.83B – 23.81B
+5.9% YoY
|
25.53B
24.56B – 26.39B
+9.0% YoY
|
28.77B
26.80B – 31.92B
+12.7% YoY
|
34.53B
32.65B – 37.08B
+20.0% YoY
|
36.99B
34.98B – 39.72B
+7.1% YoY
|
| EBITDA |
2.34B
est: 2.33B (+0.5%)
|
2.41B
est: 2.69B (-10.7%)
|
1.99B
est: 2.55B (-21.8%)
|
3.65B
est: 3.17B (+15.2%)
|
8.30B
est: 3.50B (+137.1%)
|
5.31B
est: 4.88B (+8.9%)
|
5.09B
est: 5.05B (+0.8%)
|
5.38B
5.24B – 5.47B
+6.5% YoY
|
5.86B
5.64B – 6.06B
+9.0% YoY
|
6.61B
6.16B – 7.33B
+12.7% YoY
|
7.93B
7.50B – 8.52B
+20.0% YoY
|
8.50B
8.03B – 9.12B
+7.1% YoY
|
| EBIT |
2.17B
est: 2.07B (+4.7%)
|
2.06B
est: 2.36B (-12.8%)
|
1.53B
est: 2.13B (-28.2%)
|
3.26B
est: 2.65B (+22.7%)
|
7.83B
est: 2.93B (+167.2%)
|
4.78B
est: 4.43B (+8.0%)
|
4.61B
est: 4.39B (+4.9%)
|
4.88B
4.75B – 4.96B
+11.1% YoY
|
5.32B
5.11B – 5.50B
+9.0% YoY
|
5.99B
5.58B – 6.65B
+12.7% YoY
|
7.19B
6.80B – 7.72B
+20.0% YoY
|
7.70B
7.28B – 8.27B
+7.1% YoY
|
| Net Income |
1.36B
est: 1.44B (-5.3%)
|
1.65B
est: 1.49B (+10.6%)
|
1.20B
est: 1.71B (-29.5%)
|
2.60B
est: 2.13B (+22.1%)
|
6.18B
est: 2.35B (+163.4%)
|
4.12B
est: 4.25B (-3.2%)
|
4.10B
est: 4.14B (-0.9%)
|
3.86B
3.64B – 4.07B
-6.9% YoY
|
4.26B
3.90B – 4.65B
+10.4% YoY
|
4.69B
4.03B – 5.57B
+10.1% YoY
|
5.61B
5.49B – 5.73B
+19.7% YoY
|
6.98B
6.48B – 7.64B
+24.3% YoY
|
| SGA |
638.07M
est: 570.16M (+11.9%)
|
738.71M
est: 686.70M (+7.6%)
|
803.80M
est: 1.43B (-43.8%)
|
902.40M
est: 1.78B (-49.3%)
|
1.07B
est: 1.96B (-45.5%)
|
1.24B
est: 1.41B (-11.7%)
|
1.38B
est: 2.84B (-51.2%)
|
1.55B
1.51B – 1.58B
-45.3% YoY
|
1.69B
1.62B – 1.75B
+9.0% YoY
|
1.90B
1.77B – 2.11B
+12.7% YoY
|
2.28B
2.16B – 2.45B
+20.0% YoY
|
2.45B
2.31B – 2.63B
+7.1% YoY
|
| EPS |
44.43
est: 46.90 (-5.3%)
|
53.74
est: 54.20 (-0.8%)
|
39.24
est: 47.16 (-16.8%)
|
84.67
est: 87.59 (-3.3%)
|
201.60
est: 188.17 (+7.1%)
|
134.34
est: 138.74 (-3.2%)
|
133.89
est: 134.10 (-0.2%)
|
127.70
118.66 – 132.85
-4.8% YoY
|
140.40
127.36 – 151.82
+9.9% YoY
|
150.14
131.37 – 181.81
+6.9% YoY
|
183.00
179.13 – 186.87
+21.9% YoY
|
227.50
211.42 – 249.33
+24.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.03% | 242.0K | 0.65% |
| 2 | State Street SPDR Portfolio Emerging Markets ETF SPEM | 0.00% | 860.7K | 0.07% |
| 3 | State Street SPDR S&P Emerging Asia Pacific ETF GMF | 0.00% | 1.2K | 0.49% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Tushar Ramesh Shah | Chief Executive Officer & Whole Time Director | 59M | male |
| Jayen Ramesh Shah | MD & Director | 59M | male |
| Mukesh Maganlal Shah | Chairman & Whole Time Director | 59M | male |
| Bimal Mukesh Shah | Executive Director | 59M | male |
| Nikhil Dattatray Kamat | Senior Vice President of Operation & Whole Time Director | 20M | male |
| Pooja Bhavesh Lohor | Company Secretary & Compliance Officer | 1M | female |
| Sonali Bhadani | Chief Financial Officer | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for FINEORG.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
